KR20020039354A - 바소프레신 길항제 제형 및 방법 - Google Patents

바소프레신 길항제 제형 및 방법 Download PDF

Info

Publication number
KR20020039354A
KR20020039354A KR1020027003931A KR20027003931A KR20020039354A KR 20020039354 A KR20020039354 A KR 20020039354A KR 1020027003931 A KR1020027003931 A KR 1020027003931A KR 20027003931 A KR20027003931 A KR 20027003931A KR 20020039354 A KR20020039354 A KR 20020039354A
Authority
KR
South Korea
Prior art keywords
polysorbate
pharmaceutical composition
component
polyethylene glycol
weight
Prior art date
Application number
KR1020027003931A
Other languages
English (en)
Korean (ko)
Inventor
윤요셉규웅
사운더즈리챠드윌리엄
포지마디바키르
Original Assignee
윌리암 에이취 캘넌, 에곤 이 버그
아메리칸사이아나미드컴파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윌리암 에이취 캘넌, 에곤 이 버그, 아메리칸사이아나미드컴파니 filed Critical 윌리암 에이취 캘넌, 에곤 이 버그
Publication of KR20020039354A publication Critical patent/KR20020039354A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020027003931A 1999-09-27 2000-09-26 바소프레신 길항제 제형 및 방법 KR20020039354A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40577299A 1999-09-27 1999-09-27
US09/405,772 1999-09-27
PCT/US2000/026369 WO2001022945A1 (en) 1999-09-27 2000-09-26 Vasopressin antagonist formulation and process

Publications (1)

Publication Number Publication Date
KR20020039354A true KR20020039354A (ko) 2002-05-25

Family

ID=23605168

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027003931A KR20020039354A (ko) 1999-09-27 2000-09-26 바소프레신 길항제 제형 및 방법

Country Status (18)

Country Link
EP (1) EP1216033A1 (hu)
JP (1) JP2003510269A (hu)
KR (1) KR20020039354A (hu)
CN (1) CN1391466A (hu)
AR (1) AR025780A1 (hu)
AU (1) AU7615000A (hu)
BR (1) BR0014351A (hu)
CA (1) CA2388474A1 (hu)
CZ (1) CZ20021083A3 (hu)
EA (1) EA200200414A1 (hu)
HK (1) HK1045109A1 (hu)
HU (1) HUP0202972A3 (hu)
IL (1) IL148541A0 (hu)
MX (1) MXPA02003189A (hu)
NO (1) NO20021475L (hu)
PL (1) PL354282A1 (hu)
WO (1) WO2001022945A1 (hu)
ZA (1) ZA200203312B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2003072085A1 (fr) * 2002-02-27 2003-09-04 Shionogi & Co., Ltd. Preparations solides contenant un medicament a peine soluble dans l'eau d'une meilleure absorbabilite
JP5873375B2 (ja) * 2012-04-03 2016-03-01 中日本カプセル 株式会社 ソフトカプセル及びソフトカプセルの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
CA2318128C (en) * 1998-01-20 2008-10-14 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
HUP0202972A3 (en) 2003-07-28
NO20021475D0 (no) 2002-03-25
AU7615000A (en) 2001-04-30
MXPA02003189A (es) 2002-09-30
PL354282A1 (en) 2003-12-29
IL148541A0 (en) 2002-09-12
CA2388474A1 (en) 2001-04-05
CN1391466A (zh) 2003-01-15
EP1216033A1 (en) 2002-06-26
WO2001022945A1 (en) 2001-04-05
AR025780A1 (es) 2002-12-11
HUP0202972A2 (hu) 2002-12-28
HK1045109A1 (zh) 2002-11-15
EA200200414A1 (ru) 2002-12-26
NO20021475L (no) 2002-04-16
CZ20021083A3 (cs) 2002-06-12
BR0014351A (pt) 2002-06-11
JP2003510269A (ja) 2003-03-18
ZA200203312B (en) 2003-12-31

Similar Documents

Publication Publication Date Title
US6437006B1 (en) Pharmaceutical carrier formulation
TWI490216B (zh) 用作ｃ型肝炎病毒蛋白酶抑制劑之醫藥組合物
US6221391B1 (en) Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
NL193267C (nl) Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat.
SK13722001A3 (sk) Farmaceutický prostriedok
KR920007832B1 (ko) 고온 용융성 테르페니딘 조성물의 제조방법
JPH07196512A (ja) 医薬組成物
WO2005123133A1 (en) A process for preparing ibuprofen soft gelatin capsules
EP1344523A1 (en) Ibuprofen solution for hard gelatin capsules
US6352718B1 (en) Vasopressin antagonist formulation and process
JP5750278B2 (ja) カンデサルタンシレキセチルのカプセル充填用組成物
OA11385A (en) Formulations comprising dissolved paroxetine.
KR20020039354A (ko) 바소프레신 길항제 제형 및 방법
KR20020064289A (ko) 약제학적 담체 제형
US20020032220A1 (en) Formulations comprising dissolved paroxetine
DK169566B1 (da) Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet
WO2014010008A1 (ja) カンデサルタンシレキセチルのカプセル充填用組成物
US20030065040A1 (en) Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
AU2002240206A1 (en) Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
WO2002013789A1 (en) Pharmaceutical composition containing 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl] -1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine]
JPH0155245B2 (hu)

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid